Company profile
Globus Medical, Inc.
NYSE: GMED · Healthcare · Medical - Devices
#88 of 1,418 Healthcare companies by revenue62nd-percentile growth
EA Score
86AFH 92DQ 85GM 71SS 83
v0.1 · 65/100 weight · provisional
↑ Piotroski F, market scale · ↓ listing tenure, revenue growth (YoY)
Methodology →Revenue TTM
$3.1B
Rev growth YoY (TTM)
+23.5%
Net income (FY)
$537.9M
Employees
6,000
as of 2026-08-06
Market cap
$10.9B
as of 2026-08-06
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.9B$2.9B2025
Net income$537.9M$537.9M2025
Operating income$479.8M$479.8M2025
Total assets$5.3B$5.3B2025
Liabilities$729.5M$729.5M2025
Equity$4.6B$4.6B2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Globus Medical, Inc.’s revenue?
Globus Medical, Inc. booked $2.9B in FY2025 revenue, growing 17% year over year — faster than most Healthcare companies we track, at a 18.3% net margin.
Peers · Healthcare
MiniMed Group, Inc. Common Stock73BWest Pharmaceutical Services, Inc.86AAmneal Pharmaceuticals, Inc.75B+Neurocrine Biosciences, Inc.88ARevvity, Inc.79B+ModivCare Inc.——Neighbors
Montgomery →Key facts
CEOKeith W. Pfeil
SectorHealthcare
IndustryMedical - Devices
HeadquartersAudubon, PA
ExchangeNYSE: GMED
Employees6,000
IPO date2012-08-03
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.